Mylan Pharmaceuticals Inc. et al. vs Genentech, Inc.

Notice of Refund

MYLAN PHARMACEUTICALS INC.'S REQUEST FOR REFUND OF POST-INSTITUTION FEE AND EXCESS CLAIM FEES FOR INTER PARTES REVIEW OF U.S. PATENT NO. 6,407,213

Termination Decision Document

Parties e-mail 3-7-17

Joint Motion to Terminate Proceeding Pursuant to 35 U.S.C. 317(a)

Joint Request that Settlement Agreement be Treated as Business Confidential Information

Petitioners Updated Exhibit List

Confidential Settlement Agreement

EXPUNGED

Parties email dated Feb. 24. 2017

Order Conduct of the Proceeding

MYLAN PHARMACEUTICALS INC.'S MANDATORY NOTICE

MYLAN PHARMACEUTICALS INC.'S POWER OF ATTORNEY

Order - Patent Owner's Motions for Pro Hac Vice Admission of Robert J. Gunther, Jr. and Daralyn J. Durie - 37 CFR 42.10

Decision - Patent Owner's Motion to Seal - 37 CFR 42.14

IPR2016-01694 Gunther Pro Hac Vice Motion

Exhibit 2032 Gunther Pro Hac Vice Declaration IPR2016-01694

IPR2016-01694 Durie Pro Hac Vice Motion

Exhibit 2033 Durie Pro Hac Vice Declaration IPR2016-01694

Exhibit 2002 Genentech Laboratory Notebook 10823 Leonard Presta

Exhibit 2003 Genentech Laboratory Notebook 11268 Paul Carter

Exhibit 2005 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 10840 John Brady

Exhibit 2007 Excerpts from Genentech Laboratory Notebook 11008 Ann Rowland

Exhibit 2010 Genentech Memorandum from Paul Carter to Leonard Presta and Dennis Henner

Exhibit 2008 Excerpts from Genentech Laboratory Notebook 11297 Tim Hotaling

Exhibit 2009 Excerpts from Notebook 11568 Monique Carver

Exhibit 2011 Genentech Memorandum from Paul Carter to Leonard Presta

Exhibit 2014 Genentech Protein Engineering of 4D5 Status Report

Exhibit 2015 Genentech Memorandum re RCC Minutes and Recommendations

Exhibit 2018 PARTIES AND BOARD ONLY Declaration of John Ridgway Brady

Exhibit 2020 Presta Humanization of an Anti Vascular Endothelial Growth Factor

Exhibit 2021 PUBLIC Bruggerman The Immunogenicity of Chimeric Antibodies

Exhibit 2022 PUBLIC Kalsi Structure-function Analysis

Exhibit 2024 Isaacs Humanised Monoclonal Antibody Therapy for Rheumatoid Arthritis

Exhibit 2026 Tramontano Framework

Exhibit 2031 PUBLIC IPR2016-01694 Mylan Modified Default Standing PO

Exhibit 2029 PARTIES AND BOARD ONLY Declaration of Dr Leonard G Presta

Exhibit 2030 Declaration of Dr Paul J Carter Redacted

Exhibit 2012 Genentech, Synthetic DNA Requests

Exhibit 2013 Genentech Synthetic DNA Requests

Exhibit 2017 Mylan Modified Default Standing PO Redline

Exhibit 2018 Declaration of John Ridgway Brady Redacted

Exhibit 2030 PARTIES AND BOARD ONLY Declaration of Dr Paul J Carter

Exhibit 2028 Excerpt from Roche Finance Report 2015

Exhibit 2029 Declaration of Dr Leonard G Presta Redacted

Exhibit 2019 Carter Humanization of the Anti p185 Antibody for Human Cancer Therapy

Exhibit 2023 Gorman Reshaping a Therapeutic

Exhibit 2016 Declaration of Irene Loeffler

Exhibit 2004 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 11643 Paul Carter

Patent Owner's Preliminary Response

Exhibit 2027 SHEPARD Herceptin in Therapeutic Antibodies

Exhibit 2025 PUBLIC Kabat Sequences of Proteins of Immunological Interest 1987

Exhibit 2001 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 10098 Leonard Presta

Exhibit 2006 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 11162 John Brady

Patent Owners Preliminary Response - Confidential

Patent Owner's Motion to Seal

Notice of Accepting Corrected Petition

Patent Owner's Power of Attorney

Patent Owner's Mandatory Notices

Certification of Word Count of Petition Pursuant to 37 C.F.R. 42.24(d)

Boulianne 1984

Petitioner's Notice of and Submission of Corrected Exhibit No. 1117

Notice of Accord Filing Date - Defective Petition

File History for U.S. Patent No. 6,407,213 Part I

File History for U.S. Patent No. 6,407,213 Part II

Ball E.D., et al. J. Immunol. 128(3):1476-81 (March 1982)

Ball, E.D., et al. J. Natl Cancer Inst. 72(3):593-598 (March 1984)

Magnani, et al. Arch. Biochem. Biophys. 233(2):501-506 (September 1984)

Memoli, et al. Cancer Res. 48:7319-7322 ( December 15, 1988)

Ball E.D., et al. Blood 62(6):1203-1210 (December 1983)

Ball E.D., et al. Clin Cancer Res 1:965-972 (September 1995)

Bashey A., Ball E.D., et al. Blood 113(7):1581-1588 (2009)

Armand P. et al. J. Clin. Oncol. 31(33):4199-4206 (November 20, 2013)

Chen J, Zhou J.H., Ball E.D. Clin. Can. Res. 1:1319-1325(November 1995)

Balaian, L. and Ball, E.D. Leukemia Res. 25:1115-1125 (2001)

U.S. Patent No. 6,407,213, (issued June 18, 2002)

Ball E.D., et al. J. Hematotherapy 1:85-94 (1992)

Chen J., Ball, E.D., et al. Clin. Can. Res. 1:425-434 (April 1995)

Chen J., Ball, E.D., et al. Peptides 1994. 819-820(1995)

Ball, E.D. et al. Leukemia, 20:2093-2101 (2006)

Ball E.D. Blood (ASH Annual Meeting Abstracts) 116: Abstract 3286 (2010)

Kohler and Milstein, Nature 256(5517):495-497 (August 7, 1975)

Queen et al. Pro. Natl Acad. Sci. 86:10029-10033 (1989)

Waldmann et al. Blood 72:1705-1716 (1988)

Hakimi et al. J. Immunol. 147:1352-1359 (August 15, 1991)

Vincenti et al. N. Engl. J. Med. 338(3):161-165 (January 15, 1998)

Harris, J.R., et al. N. Engl. J. Med. 327(5):319-328 (1992)

Zhou J.H., Ball E.D., et al Peptides 1996, 935-936 (1998)

Hudziak et al. Mol. Cell Biol. 9(3):1165-1172 (March 1989)

Prabakaran Science, 349(6246):389 (July 24, 2015)

Marks, L. The story of Cesar (last accessed September 08, 2015)

Cosimi et al. Transplantation 32:535-539 (1981)

OMTSG N. Engl. J. Med. 313(6):337-342 (August 8, 1985)

Jaffers et al. Transplantation 41(5):572-578 (1986)

Sears et al. The Lancet 762-765 (April 3, 1982)

Sikora J. Clin. Pathol. 35:369-375 (1982)

Protein Data Bank ¿¿¿ Chronology (accessed August 29, 2016)

Morrison et al., Pro. Natl Acad. Sci. 81:6851-6855 (November 1984).

Liu et al., Pro. Natl Acad. Sci. 84:3439-3443 (May 1987).

Jones et al. Nature 321:522-525 (1986)

Kirkman et al., Transplant. Proc. 21:1766-1768 (1989)

SEER Stat Fact Sheets (last accessed September 08, 2015)

Coussens L., et al. Science 230:1132-1139 (December 6, 1985)

King et al. Science 229:974-976 (1985)

Semba K., et al. Pro. Natl Acad. Sci. 82:6497-6501 (1985)

Fukushige S., et al. Mol. Cell. Biol. 6:955-958 (1986)

Slamon, D.J. et al. Science 235:177-182 (1987)

Hudziak, R. M., et al. Pro. Natl Acad. Sci. 84:7159-7163 (1987)

Shepard, H. M. et al. Journal of Clinical Immunology, 11(3):117-127 (1991).

Queen WO199007861 (published July 26, 1990)

Milstein, et al. Proc. Royal Soc. London 211:393-412 (March 27, 1981)

Johnson and Wu, Methods in Molecular Biology 248:11-25 (December 2003)

Davies & Metzger, Annu. Rev. Immunol. 1:87-117 (1983)

Amit et al. Science 233:747-53 (1986)

Lascombe et al. Pro. Natl Acad. Sci. 86:607-611 (January 1989)

Novotny et al. J. Biol. Chem. 258(23):14433-14437 (December 10, 1983)

Chothia and Lesk, J. Mol. Biol. 196:901-917 (1987)

Kraus, M.H., et al. The EMBO Journal 6(3):605-610 (1987)

Chothia, C. et al. Nature 342(21):877-883 (December 1989).

Tramontano, A. et al. J. Mol. Biol. 215:175-182 (1990)

Kabat, et al. National Institutes of Health, Bethesda, Md. (1987)

Wu and Kabat, J. Exp. Med. 132:211-250 (1970)

Kieber-Emmons et al. Intern. Rev. Immunol. 2:339-356 (1987)

Chothia et al. J. Mol. Biol. 186:651-63 (1985)

Tjandra et al. Immunol. Cell. Biol. 68:367-76 (1990)

Mountain. Biotech. Genet. Eng. Rev. 10:1-142 (1992)

Verhoeyen, Science 239:1534- 1536 (March 25, 1988)

Verhoeyen, Science 239:1534- 1536 (March 25, 1988)

Kurrle, et al. EP0403156. (1990)

Van Kroonenburgh Nucl. Med. Commun. 9:919-30 (1988)

Lind, et al. Antibod. Immunoconj. Radiopharm. 4(4):811-818 (1991)

Tempest, et al. BioTechnology 9:266-271 (March 1991)

Shearman, et al. J. Immunol. 147(12):4366-4373, (December 15, 1991)

Accelrys Inc. (Last accessed October 16, 2015)

Dayringer et al. J. Mol. Graphics 4(2):82-87 (1986)

Loew, G. et al. Int. J. Quant. Chem. Quant. Biol. 15:55-66 (1988)

Bruccoleri et al. Nature 335(6):564-568 (1988)

Chothia et al. Science New Series, 233(4765):755-758 (August 15, 1986)

Bernstein et al. J. Mol. Biol. 112:535-542 (1977)

Sheriff et al. Proc. Natl Acad. Sci. U.S.A. 84:8075 (1987)

Marquart et al. Immun. Today 3(6):160-166 (1982)

Saul et al. J. Biol. Chem. 253:585 (1978)

Padlan et al. Proc. Nat¿¿¿l Acad. Sci. 86:5938-5942 (August 1989)

Winter et al. EP0239400 Published September 30, 1987.

Kabat et al. (National Institutes of Health, Bethesda, Md.) (1983).

Navia et al. Proc. Natl. Acad. Sci. 76(8):4071-4074 (August 1979)

Satow et al. J. Mol. Biol. 190:593-604 (1986)

Herron et al. Proteins 5:271-280 (1989)

Kumar et al. Mol. Cell. Biol. 11(2):979-986 (February 1991)

Soomro et al. J. Clin. Pathol. 44:211-14 (1991)

Wilson, Protein sequencing, 170-173 (3rd ed., 1986)

Edelman et al. Proc. Natl Acad. Sci 63:78-85 (1969)

Capra, J. Proc. Natl Acad. Sci. 71:845-8 (1974)

Morin, Oncogene 19:6574- 6583 (2000)

FH U.S. Patent Application No. 07/715,272 filed June 14, 1991.

US Patent No. 5,677,171 (Issued October 14, 1997).

Daugherty et al., Nucl. Acids Res. 19(9):2471-2476 (May 1991).

Padlan and Kabat, Meth. Enzymol. 203:3 (1991).

Koprowski et al., Proc. Natl. Acad. Sci. U.S.A. 81:216 (1984)

Schroff et al. Cancer Res. 45:879 (1985)

Harris, L.J. et al. Nature 360:369-72 (1992)

Janeway et al., IMMUNOBIOLOGY 4th ed., NY, (1999)

Potter, M. Physiol. Rev. 52:631-719 (1972)

Davies et al. Ann. Rev. Biochem. 59:439-73 (1990)

Mian, I.S. J. Mol. Biol. 217:133-51 (1991)

Poljak et al. Proc. Natl Acad. Sci. U.S.A. 71:3440-4 (1974)

EXPUNGED

Padlan, E.A. Mol. Immunol. 28:489-98 (1991)

U.S. Patent No. 6,797,492 (Issued September 28, 2004)

Padlan, Eduardo Abstract (December 16-18, 1991)

U.S. Patent No. 5,792,852 (Issued August 11, 1998)

U.S. Patent No. 5,889,157 (Issued March 30, 1999)

U.S. Patent No. 4,891,762 (Issued January 2, 1990)

Wallick, S. et al. J. Exp. Med. 168:1099-109 (1988)

US Patent No. 5,677,171 (Issued October 14, 1997)

Sambrook et al., Molecular Cloning (1989)

Colman et al. Nature 326:358 (1987)

Tulip et al. Cold Spring Harbor Symp. Quant. Biol. 4:257 (1989)

Bender et al. Rheumatol. Int. 27:269-74 (2007)

Brient, J Exp Med. 132:951-62 (1970)

Chanh et al. Proc. Natl. Acad. Sci. U.S.A. 84:3891 (1987)

Abdou et al. J. Clin. Invest. 67:1297 (1981)

Kabat Ann. NY Acad. Sci. 190:382-93 (1971)

Epp et al. Biochem. 14:4943 (1975)

Padlan et al. Cold Spring Harbor Symp. Quant. Biol. 41:627-37 (1977)

Suh et al. Proteins 1:74 (1986)

US Patent No. 5,795,965 (Issued August 18, 1998)

Furey et al. J. Mol. Biol. 167:661-92 (1983)

Segal et al. Proc. Natl Acad. Sci. U.S.A. 71:4298 (1974)

Jones, TA Meth. Enzymol. 115:157-71 (1985)

Co, M. et al. Proc. Natl Acad. Sci. U.S.A. 88:2869-73 (1991)

History of Microsoft Excel 1978-2013 (accessed August 29, 2016)

Petitioner Mylan Pharmaceuticals Inc.'s Power of Attorney

Kabat 1991

Expert Declaration of Edward Ball M.D.

Exhibit 1003 B - Materials Reviewed by Dr. Eduardo A. Padlan

Petition for Inter Partes Review US Patent No. 6,407,213

Expert Declaration of Eduardo A. Padlan

Exhibit 1003 A - Dr. Eduardo A. Padlan's CV

Exhibit 1003C - Exhibits A-O of Dr. Eduardo A. Padlan